United StatesMěiguó美国FDAShípǐn Yàopǐn Jiāndū Guǎnlǐjú食品药品监督管理局approvedpīzhǔn批准Eli LillyLǐlái礼来newxīnxíng新型weight-loss pilljiǎnféi yàopiàn减肥药片Foundayo (brand name)FoundayoFoundayo。
United States
Měiguó
美国
FDA
Shípǐn Yàopǐn Jiāndū Guǎnlǐjú
食品药品监督管理局
approved
pīzhǔn
批准
Eli Lilly
Lǐlái
礼来
new
xīnxíng
新型
weight-loss pill
jiǎnféi yàopiàn
减肥药片
Foundayo (brand name)
Foundayo
Foundayo
United States
Měiguó
美国
FDA
Shípǐn Yàopǐn Jiāndū Guǎnlǐjú
食品药品监督管理局
on
yú
于
April 1
sì yuè yī rì
四月一日
approved
pīzhǔn
批准
Eli Lilly
Lǐlái
礼来
company
gōngsī
公司
(possessive particle)
de
的
weight-loss pill
jiǎnféi yàopiàn
减肥药片
Foundayo
Foundayo
Foundayo
this is
zhèshì
这是
a type of
yī zhǒng
一种
can
kěyǐ
可以
at
zài
在
any
rènhé
任何
time
shíjiān
时间
be taken
fúyòng
服用
(particle)
de
的
oral
kǒufú
口服
weight-loss drug
jiǎnféi yào
减肥药
clinical
línchuáng
临床
trial
shìyàn
试验
showed
xiǎnshì
显示
patients
huànzhě
患者
on average
píngjūn
平均
lost
jiǎnqīng le
减轻了
about 12 percent
yuē bǎifēnzhī shí èr
约12%
body weight
tǐzhòng
体重
April 2, 2026 at 2:00 PM
United States
Měiguó
美国
FDA
Shípǐn Yàopǐn Jiāndū Guǎnlǐjú
食品药品监督管理局
on
yú
于
April 1
sì yuè yī rì
四月一日
approved
pīzhǔn
批准
Eli Lilly
Lǐlái
礼来
company
gōngsī
公司
(possessive particle)
de
的
new
xīnxíng
新型
weight-loss drug
jiǎnféi yào
减肥药
Foundayo
Foundayo
Foundayo
this drug
zhè zhǒng yào
这种药
(possessive particle)
de
的
generic name
tōngyòng míng
通用名
is
shì
是
orforglipron
Àofúgèlièpùlún
奥福格列普仑
belongs to
shǔyú
属于
GLP-1
GLP-1
GLP-1
class of
lèi
类
drugs
yàowù
药物
GLP-1
GLP-1
GLP-1
class of drugs
lèi yàowù
类药物
can
kěyǐ
可以
mimic
mófǎng
模仿
the human body
réntǐ
人体
natural
tiānrán
天然
(possessive particle)
de
的
feeling of fullness
bǎofùgǎn
饱腹感
hormone
jīsù
激素
helping
bāngzhù
帮助
people
rénmen
人们
reduce
jiǎnshǎo
减少
appetite
shíyù
食欲
clinical
línchuáng
临床
trial
shìyàn
试验
showed
xiǎnshì
显示
taking
fúyòng
服用
the highest
zuìgāo
最高
dose
jìliàng
剂量
(possessive particle)
de
的
patients
huànzhě
患者
in
zài
在
72 weeks
qī shí èr zhōu
72周
within
nèi
内
on average
píngjūn
平均
lost
jiǎnqīng le
减轻了
about 27 pounds
yuē èr shí qī bàng
约27磅
or
jí
即
12.4 percent
bǎifēnzhī shí èr diǎn sì
12.4%
(particle)
de
的
body weight
tǐzhòng
体重
compared to
yǔ
与
other
qítā
其他
weight-loss drugs
jiǎnféi yào
减肥药
differently
bùtóng
不同
Foundayo
Foundayo
Foundayo
can
kěyǐ
可以
at
zài
在
any time of day
yī tiān zhōng
一天中
(particle)
de
的
any
rènhé
任何
time
shíjiān
时间
be taken
fúyòng
服用
no need for
bù xūyào
不需要
empty stomach
kōngfù
空腹
using
shǐyòng
使用
Eli Lilly
Lǐlái
礼来
coupon
yōuhuìquàn
优惠券
after
hòu
后
each month
měi yuè
每月
cost
fèiyòng
费用
approximately
yuēwéi
约为
$25
èr shí wǔ měiyuán
25美元
this is
zhèshì
这是
FDA
Shípǐn Yàopǐn Jiāndū Guǎnlǐjú
食品药品监督管理局
to date
qìjīn
迄今
approved
pīzhǔn
批准
speed
sùdù
速度
fastest
zuìkuài
最快
(particle)
de
的
weight-loss drug
jiǎnféi yào
减肥药
one of
zhī yī
之一
from
cóng
从
application
shēnqǐng
申请
to
dào
到
approval
huòpī
获批
only
jǐn
仅
took
huā le
花了
50 days
wǔ shí tiān
50天
Eli Lilly
Lǐlái
礼来
company
gōngsī
公司
stated
biǎoshì
表示
Foundayo
Foundayo
Foundayo
has already
yǐjīng
已经
started
kāishǐ
开始
through
tōngguò
通过
its
qí
其
direct sales
zhíxiāo
直销
platform
píngtái
平台
to
xiàng
向
patients
huànzhě
患者
shipping
fāhuò
发货
News in English
Lifestyle & CultureFDA Approves Eli Lilly Obesity Pill Foundayo in Record 50 Days
The FDA approved Eli Lilly obesity pill Foundayo on April 1, 2026, a GLP-1 oral medication patients can take at any time of day, with clinical trials showing average body weight loss of about 12 percent over 72 weeks.
More in Lifestyle & Culture
Arsenal (football club)Āsēnnà阿森纳to advance into / to push forward totǐnɡjìn挺进UEFA Champions LeagueŌuɡuàn欧冠final / championship matchjuésài决赛，to face / to compete againstduìzhèn对阵Paris Saint-Germain (PSG)Bālí Shènɡ Rì'ěrmàn巴黎圣日耳曼。
Arsenal (football club)
Āsēnnà
阿森纳
to advance into / to push forward to
tǐnɡjìn
挺进
UEFA Champions League
Ōuɡuàn
欧冠
final / championship match
juésài
决赛
to face / to compete against
duìzhèn
对阵
Paris Saint-Germain (PSG)
Bālí Shènɡ Rì'ěrmàn
巴黎圣日耳曼
Arsenal Reach Champions League Final to Face Paris Saint-Germain
NASAMěiguó Hángtiānjú美国航天局Nancy Grace Roman (astronomer)Nán Xī Gé Lěi Zī Luómàn南希·格蕾丝·罗曼space telescopetàikōng wàngyuǎnjìng太空望远镜to launchfāshè发射time / dateshíjiān时间moved up to / advanced totíqián zhì提前至September 20262026 nián 9 yuè2026年9月。
NASA
Měiguó Hángtiānjú
美国航天局
Nancy Grace Roman (astronomer)
Nán Xī Gé Lěi Zī Luómàn
南希·格蕾丝·罗曼
space telescope
tàikōng wàngyuǎnjìng
太空望远镜
to launch
fāshè
发射
time / date
shíjiān
时间
moved up to / advanced to
tíqián zhì
提前至
September 2026
2026 nián 9 yuè
2026年9月
NASA Roman Space Telescope Launch Moved Up to September 2026
Novak DjokovicDéyuē Kēwéiqí德约科维奇to advance / to qualifyjìnjí晋级French Open / Roland GarrosFǎwǎng法网third rounddì sān lún第三轮，willjiāng将to face / to take on (in competition)yíngzhàn迎战19-year-old19 suì19岁structural particlede的Joao FonsecaFēngsāikǎ丰塞卡。
Novak Djokovic
Déyuē Kēwéiqí
德约科维奇
to advance / to qualify
jìnjí
晋级
French Open / Roland Garros
Fǎwǎng
法网
third round
dì sān lún
第三轮
will
jiāng
将
to face / to take on (in competition)
yíngzhàn
迎战
19-year-old
19 suì
19岁
structural particle
de
的
Joao Fonseca
Fēngsāikǎ
丰塞卡
Djokovic Reaches Roland Garros Round Three to Face 19-Year-Old Fonseca
United KingdomYīngguó英国Maywǔyuè五月temperature / air temperatureqìwēn气温consecutive / in a rowliánxù连续two daysliǎng tiān两天to break (a record)pò破historical recordlìshǐ jìlù历史纪录。
United Kingdom
Yīngguó
英国
May
wǔyuè
五月
temperature / air temperature
qìwēn
气温
consecutive / in a row
liánxù
连续
two days
liǎng tiān
两天
to break (a record)
pò
破
historical record
lìshǐ jìlù
历史纪录
UK May Temperature Record Broken for Two Consecutive Days